Oncology Institute Inc (TOI): Next-Year EPS Estimate 46.67%
As of 2026-06-11, Oncology Institute Inc (TOI) has a next-year EPS growth estimate of 46.67%.
On 2026-05-19, analyst consensus for TOI's next-year EPS growth shifted from 37.93% to 46.67% — a positive change of 8.74 percentage points. The revised estimate has been sustained across 18 subsequent trading sessions. Current-year growth is projected at 72.22%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- EPS growth next year
- 46.67%
- EPS growth this year
- 72.22%
- EPS next quarter (est)
- -$0.07
- Last price
- $5.13
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 46.67% | 72.22% | -$0.07 | $5.13 |
| 2026-06-10 | 46.67% | 72.22% | -$0.07 | $4.68 |
| 2026-06-09 | 46.67% | 72.22% | -$0.07 | $4.96 |
| 2026-06-08 | 46.67% | 72.22% | -$0.07 | $5.07 |
| 2026-06-07 | 46.67% | 72.22% | -$0.07 | $4.87 |
| 2026-06-04 | 46.67% | 72.22% | -$0.07 | $4.74 |
| 2026-06-03 | 46.67% | 72.22% | -$0.07 | $4.23 |
| 2026-06-02 | 46.67% | 72.22% | -$0.07 | $4.59 |
| 2026-06-01 | 46.67% | 72.22% | -$0.07 | $4.78 |
| 2026-05-31 | 46.67% | 72.22% | -$0.07 | $4.69 |
| 2026-05-28 | 46.67% | 72.22% | -$0.07 | $4.71 |
| 2026-05-27 | 46.67% | 72.22% | -$0.07 | $4.61 |
| 2026-05-26 | 46.67% | 72.22% | -$0.07 | $4.59 |
| 2026-05-25 | 46.67% | 72.22% | -$0.07 | $4.59 |
| 2026-05-24 | 46.67% | 72.22% | -$0.07 | $4.59 |
| 2026-05-21 | 46.67% | 72.22% | -$0.07 | $4.47 |
| 2026-05-20 | 46.67% | 72.22% | -$0.07 | $4.20 |
| 2026-05-19 | 46.67% | 72.22% | -$0.07 | $4.10 |
| 2026-05-18 | 37.93% | 73.15% | -$0.07 | $4.00 |
| 2026-05-17 | 37.93% | 73.15% | -$0.07 | $3.98 |
| 2026-05-14 | 37.93% | 73.15% | -$0.07 | $4.04 |
| 2026-05-13 | 37.93% | 73.15% | -$0.07 | $4.12 |
| 2026-05-12 | 37.93% | 73.15% | -$0.07 | $4.02 |
| 2026-05-11 | 37.93% | 73.15% | -$0.07 | $4.01 |
| 2026-05-10 | 53.85% | 69.91% | -$0.06 | $4.00 |
| 2026-05-07 | 64.84% | 57.87% | -$0.09 | $4.07 |
| 2026-05-06 | 64.84% | 57.87% | -$0.09 | $3.80 |
| 2026-05-05 | 64.84% | 57.87% | -$0.09 | $3.98 |
| 2026-05-04 | 64.84% | 57.87% | -$0.09 | $4.08 |
| 2026-05-03 | 64.84% | 57.87% | -$0.08 | $4.05 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Oncology Institute Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Oncology Institute Inc (TOI) has a next-year EPS growth estimate of 46.67%, based on analyst consensus.
When was the latest EPS estimate revision for TOI?▾
The most recent revision occurred on 2026-05-19, when analysts adjusted the next-year EPS growth estimate from 37.93% to 46.67%.
What sector and industry does Oncology Institute Inc belong to?▾
Oncology Institute Inc operates in the Healthcare sector, specifically the Medical Care Facilities industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TOI appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Oncology Institute Inc (TOI) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports